Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4292 +0.0080 (+1.90%) Streaming Delayed Price Updated: 3:55 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Enveric Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies October 04, 2024 Companies are developing safer, targeted psychedelic therapies aimed at reducing risks and improving mental health treatment options. Via Benzinga Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research September 25, 2024 Psychedelics biotech company Enveric Biosciences (NASDAQ: ENVB) has presented research highlighting the company's lead compound, EB-003 at the 7th Neuropsychiatric Drug Summit. The conference is being... Via Benzinga ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q2 2024 August 12, 2024 ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Why Is Imunon (IMNN) Stock Up 259% Today? July 30, 2024 Imunon stock is up on Tuesday with heavy trading of IMNN shares after posting positive results from a Phase 2 clinical trial. Via InvestorPlace Why Is Ekso Bionics (EKSO) Stock Down 15% Today? July 30, 2024 Ekso Bionics stock is down on Tuesday as investors in the company react to its lackluster earnings report for the second quarter of the year. Via InvestorPlace Why Is Enveric Biosciences (ENVB) Stock Up 18% Today? July 30, 2024 Enveric Biosciences stock is up on Tuesday with heavy trading of ENVB shares despite a lack of news from the company this morning. Via InvestorPlace Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 30, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 30, 2024 Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning! Via InvestorPlace Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket July 30, 2024 Via Benzinga Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally July 25, 2024 Via Benzinga New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies July 11, 2024 Enveric Biosciences has been granted a U.S. patent for EB-002, enhancing protection for treatments targeting brain neurological disorders, including depression and anxiety. Via Benzinga Topics Intellectual Property Exposures Intellectual Property ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q1 2024 May 20, 2024 ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand May 16, 2024 Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe the first quarter of 2024 was a highly productive period for Enveric as the... Via Benzinga Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate May 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods May 08, 2024 The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as a Schedule III controlled substance. Via Benzinga Topics Cannabis Exposures Cannabis Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 03, 2024 Via Benzinga Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 03, 2024 Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... Via Benzinga Exposures Glyphosate 12 Health Care Stocks Moving In Tuesday's After-Market Session April 02, 2024 Via Benzinga ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q4 2023 April 01, 2024 ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth March 27, 2024 Via Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates 12 Health Care Stocks Moving In Tuesday's After-Market Session March 19, 2024 Via Benzinga Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 19, 2024 Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Via Benzinga Nasdaq Down 100 Points; US Housing Starts Surge In February March 19, 2024 U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.11% to 38,831.86 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday? March 19, 2024 Enveric Biosciences announces significant progress with non-binding term sheets signed with a biotech firm for cannabinoid-COX-2 conjugate compounds, targeting joint diseases. These agreements could... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 19, 2024 Via Benzinga Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.